We are an international group based in Parma, research-oriented, with over 85 years of experience, present in 31 countries. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being).
Since 2019 we are a certified B Corp, while, in 2018, we changed our legal status to a Benefit Company, realizing the desire to measure our impact on society and the environment, combining the need to generate value for the business to acting as a positive force for the community in which we live.
More than 6,500 Chiesi people around the world, of which more than 600 are dedicated to research and development.